• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct29
Edesa Biotech's EB05 Shows Positive Results in Phase 3 Clinical Trials for ARDS
10:21
Sep30
Edesa Biotech Inc. revises financing agreement with the Canadian government for ARDS drug development
20:15
Aug9
Edesa Biotech released FY2025 9 Months Earnings on August 8 (EST), actual revenue USD 0, actual EPS USD -1.0323
03:00
Edesa Biotech released FY2025 Q3 earnings on August 8, 2025 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -0.2491 (forecast USD -0.2633)
03:00
May15
Edesa Biotech released FY2025 Semi-Annual Earnings on May 14 (EST), with actual revenue of USD 0 and EPS of USD -0.7434
03:00
Edesa Biotech released FY2025 Q2 earnings on May 14, 2025 (EST), with actual revenue USD 0 (forecast USD 0) and actual EPS USD -0.2997 (forecast USD -0.295)
03:00

Schedules & Filings

Schedules
Filings
Aug8
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -1.749 M, EPS -0.2491

May14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -1.59 M, EPS -0.2997

Feb14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -1.617 M, EPS -0.4834

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SMX
430.690
+205.45%
+289.690
TGL
13.830
+104.65%
+7.072
GURE
9.670
+104.01%
+4.930
WHLR
6.355
+96.15%
+3.100
TDIC
0.4016
+43.02%
+0.121
IRBT
4.240
+39.93%
+1.219
PRAX
254.690
+34.07%
+64.720
DBRG
12.840
+32.10%
+3.120
YYAI
1.350
+29.81%
+0.313
ULY
2.413
+29.04%
+0.543
View More